Discover the next frontier in cervical cancer screening.
Join BioPerfectus upcoming webinar to explore how genotype-specific HPV viral load quantification is transforming clinical decision-making worldwide.

🔬 What to Expect:
✅ Global Guidelines Insight: Consensus on HPV viral load standardization from leading guidelines.
✅ Breakthrough 21-genotype assay + single-copy normalization.
✅ Evidence-Driven Validation: Proof from clinical studies, aligned with international standards.
✅ Critical Clinical Value: Role of HPV viral load in cervical lesion risk stratification, treatment efficacy tracking, and prognosis monitoring.

🎤 Featured Speaker:
Prof. Pengming Sun, MD, PhD
WHO Guideline Panel Member | VP, Fujian MCH Hospital

📌 Save your seat now and be part of the future of cervical cancer prevention:
https://hub.bioperfectus.com/worlds-first-hpv-genotyping-normalized-quantification-assay